Atunga Nyachieo, PhD

Kenya Institute of Primate Research (KIPRE)

Dr. Atunga Nyachieo is a Senior Research Scientist and Chief of Research (scientific leader) at the Institute of Primate Research, Nairobi, Kenya. He is a well-seasoned senior researcher and an excellent student mentor. Dr. Nyachieo was attracted to phage research after reading online publications and campaigns by the Phages for Global Health foundation, showing that phages can be used for therapy. Since then he has re-focused his research and ventured into phage biology for therapy as alternative to antimicrobials. With the support of well-wishers, he has put up a phage biology team called “Phage Hunting Group” aimed at isolating phages as well as creating awareness on this novel technology. He and his team members (mainly students) have isolated and characterized phages against wound causing multidrug resistant Staphylococcus aureas (4 publications on phage biology) and E. coli and Salmonella. He strongly believes that training and research on phage therapy is the key to good and healthful life. He is currently appealing for donations to support phage training and research.

Loading issues…

Phage training reaches East AfricaThis week, Dr. Atunga Nyachieo and Ivy Mutai of the Institute of Primate Research in Nairobi, Kenya tell us about how phage research training began at their institute in 2017, how it continues to grow, and the impact it's had so far.Issue 54Nov 28, 2019Atunga Nyachieo, Ivy Jepkurui Mutai

Source-reported research

Research context

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. As of 2026-10-22. Reviewed 2026-10-22.

The collected paper is a Kenyan Neisseria gonorrhoeae prevalence and resistance meta-analysis; its conclusion mentions phage therapy among alternatives for future exploration. [1]

Sources and review

doi.org Observed 2026-10-22. Abstract/title supporting publication-history context

Reviewed by ai:codex-identities-ce68394c9be2. Reviewed every cited source quote and accepted paper link. This is dated publication-history context, with peripheral or predicted evidence explicit, not current work/employment or individual contribution. Draft Codex delegation gpt-6-luna/xhigh; named coordinator final review.

Source-selected papers

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. Reviewed 2026-10-24.

Evaluating The Effectiveness of A Non-Locally Developed Commercial Phage Cocktail on Kenyan Pseudomonas aeruginosa Isolates (2023)
Listed author: Atunga NYACHIEO. Selection: curated. Historical curated phage-relevant work from the supplied ORCID bibliography, matched to its own DOI and primary author. Not a greatest-work claim. [4] [5] [6] [7]

Sources and review

phage.directory Observed 2026-10-22. Native directory-recorded ORCID anchor; not an inferred global identity
pub.orcid.org Observed 2026-10-24. Exact supplied ORCID source endpoint
pub.orcid.org Observed 2026-10-24. Declared join of ORCID given/family fields; no global alias decision
api.crossref.org Observed 2026-10-24. Own DOI in primary publisher metadata
api.crossref.org Observed 2026-10-24. Decoded own DOI title
api.crossref.org Observed 2026-10-24. One-based primary author slot; declared raw given/family join
pub.orcid.org Observed 2026-10-24. Same DOI listed in supplied ORCID record

Reviewed by ai:codex-identities-ce68394c9be2. Supplied native ORCID plus consistent registry identity, own DOI membership and publisher author evidence; exact author-slot ORCID where provided, otherwise unique exact full registry-name byline with no conflicting publisher ORCID. Curated older work is dated; no greatest-work claim. One consolidated coordinator source review of this finite89-person pass. Source drafts: gpt-6-luna/xhigh leaves. Prior accepted records/native IDs preserved; no global person/name merge or Scholar requirement.